Toronto, Ontario--(Newsfile Corp. - Le 28 mars/March 2022) - The common shares of GeneTether Therapeutics Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

GeneTether Therapeutics is an innovative genetic medicines company focused on...